• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚美辛成功闭合动脉导管未闭的预测因素。

Predictors of successful closure of patent ductus arteriosus with indomethacin.

作者信息

Ahamed M F, Verma P, Lee S, Vega M, Wang D, Kim M, Fuloria M

机构信息

Division of Neonatal-Perinatal Medicine, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA.

Division of Neonatology, Alpert Medical School of Brown University, Providence, RI, USA.

出版信息

J Perinatol. 2015 Sep;35(9):729-34. doi: 10.1038/jp.2015.33. Epub 2015 Apr 9.

DOI:10.1038/jp.2015.33
PMID:25856764
Abstract

OBJECTIVE

To determine whether platelet counts can predict the likelihood of successful closure of patent ductus arteriosus (PDA) with indomethacin.

STUDY DESIGN

This was a retrospective cohort study of infants <32 weeks' gestational age (GA) and birth weight <1500 g with PDA. Clinical characteristics between infants who achieved ductal closure with indomethacin and those who failed were compared. Multivariable logistic regression was used to identify predictors of successful ductal closure.

RESULTS

In infants with hemodynamically significant PDA, older GA (odds ratio=1.54; 95% confidence interval: 1.12 to 2.13), male gender (odds ratio=3.02; 95% confidence interval: 1.08 to 8.49) and higher platelet count (odds ratio=1.5; 95% confidence interval: 1.04 to 2.17) prior to indomethacin treatment were associated with successful ductal closure with indomethacin.

CONCLUSION

Older GA, male gender and higher platelet count at time of treatment of hemodynamically significant PDA are predictors of successful ductal closure with indomethacin.

摘要

目的

确定血小板计数是否能够预测吲哚美辛成功闭合动脉导管未闭(PDA)的可能性。

研究设计

这是一项针对胎龄小于32周、出生体重小于1500g且患有PDA的婴儿的回顾性队列研究。比较了使用吲哚美辛实现导管闭合的婴儿与未实现闭合的婴儿之间的临床特征。采用多变量逻辑回归来确定导管成功闭合的预测因素。

结果

在血流动力学显著的PDA婴儿中,吲哚美辛治疗前胎龄较大(比值比=1.54;95%置信区间:1.12至2.13)、男性(比值比=3.02;95%置信区间:1.08至8.49)以及血小板计数较高(比值比=1.5;95%置信区间:1.04至2.17)与吲哚美辛成功闭合导管相关。

结论

血流动力学显著的PDA治疗时胎龄较大、男性以及血小板计数较高是吲哚美辛成功闭合导管的预测因素。

相似文献

1
Predictors of successful closure of patent ductus arteriosus with indomethacin.吲哚美辛成功闭合动脉导管未闭的预测因素。
J Perinatol. 2015 Sep;35(9):729-34. doi: 10.1038/jp.2015.33. Epub 2015 Apr 9.
2
Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus.极低出生体重儿动脉导管重新开放的临床特征
Pediatr Int. 2011 Jun;53(3):322-7. doi: 10.1111/j.1442-200X.2010.03251.x.
3
Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.极低出生体重儿使用吲哚美辛成功闭合血流动力学显著的动脉导管未闭的影响因素。
World J Pediatr. 2008 May;4(2):91-6. doi: 10.1007/s12519-008-0017-7.
4
Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus.碱剩余和红细胞压积预测对动脉导管未闭极低出生体重儿吲哚美辛的反应。
Ital J Pediatr. 2019 Aug 22;45(1):107. doi: 10.1186/s13052-019-0706-y.
5
Comparison of two neonatal indomethacin protocols: efficacy and outcome for patent ductus arteriosus closure.两种新生儿吲哚美辛方案的比较:动脉导管未闭闭合的疗效和结局。
J Clin Pharm Ther. 2010 Oct;35(5):589-92. doi: 10.1111/j.1365-2710.2009.01142.x.
6
Predictors of failed closure of patent ductus arteriosus with indomethacin.吲哚美辛治疗动脉导管未闭闭合失败的预测因素
Singapore Med J. 2006 Sep;47(9):763-8.
7
Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.动脉导管未闭保守治疗策略的潜在意外后果。
Congenit Heart Dis. 2016 Jan-Feb;11(1):52-7. doi: 10.1111/chd.12287. Epub 2015 Jul 20.
8
Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.比较口服布洛芬和静脉用吲哚美辛在韩国患有动脉导管未闭的婴儿中的应用。
Arch Pharm Res. 2012 Sep;35(9):1673-83. doi: 10.1007/s12272-012-0919-8. Epub 2012 Oct 9.
9
Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.逐步递增法使用吲哚美辛治疗孕33周以下早产儿有症状动脉导管未闭的有效性及副作用。
Pediatrics. 2005 Dec;116(6):1361-6. doi: 10.1542/peds.2005-0293.
10
Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.口服布洛芬和吲哚美辛治疗早产儿动脉导管未闭:拉玛蒂博迪医院的一项随机试验
J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1252-8.

引用本文的文献

1
Development and Validation of a Novel Deep Learning Model to Predict Pharmacologic Closure of Patent Ductus Arteriosus in Premature Infants.一种用于预测早产儿动脉导管未闭药物闭合的新型深度学习模型的开发与验证
J Am Soc Echocardiogr. 2025 Jul;38(7):624-632. doi: 10.1016/j.echo.2025.03.018. Epub 2025 Apr 11.
2
Perinatal Factors Associated with Successful Pharmacologic Closure of the Patent Ductus Arteriosus in Premature Infants.与早产儿动脉导管未闭药物成功闭合相关的围产期因素
Pediatr Cardiol. 2024 Aug 21. doi: 10.1007/s00246-024-03626-2.
3
Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants.

本文引用的文献

1
Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants.血小板计数和体积与早产儿动脉导管未闭的自然和药物闭合之间的关系。
Am J Perinatol. 2013 May;30(5):359-64. doi: 10.1055/s-0032-1324702. Epub 2012 Aug 23.
2
Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus.出生后 24 小时内血小板减少症与动脉导管未闭的发生率。
Pediatrics. 2012 Sep;130(3):e623-30. doi: 10.1542/peds.2012-0499. Epub 2012 Aug 6.
3
Low platelet count is associated with ductus arteriosus patency in preterm newborns.
早产儿动脉导管未闭使用布洛芬治疗时液体平衡与治疗结果之间的关联。
Rev Cardiovasc Med. 2023 Mar 3;24(3):78. doi: 10.31083/j.rcm2403078. eCollection 2023 Mar.
4
Impact of sex, race, and social determinants of health on neonatal outcomes.性别、种族及健康的社会决定因素对新生儿结局的影响。
Front Pediatr. 2024 Apr 9;12:1377195. doi: 10.3389/fped.2024.1377195. eCollection 2024.
5
Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.血流动力学显著的动脉导管未闭早产儿对一线对乙酰氨基酚治疗反应的临床和超声心动图预测因素
J Perinatol. 2024 Mar;44(3):379-387. doi: 10.1038/s41372-024-01883-w. Epub 2024 Jan 31.
6
Response to Therapeutic Interventions in the NICU: Role of Sex as a Biological Variable.新生儿重症监护病房治疗干预的反应:性别作为生物学变量的作用。
Neoreviews. 2023 Dec 1;24(12):e797-e805. doi: 10.1542/neo.24-12-e797.
7
Neonatal acute kidney injury during indomethacin therapy: does it predict ductal closure?吲哚美辛治疗新生儿急性肾损伤:是否预测动脉导管关闭?
J Nephrol. 2023 Jul;36(6):1591-1597. doi: 10.1007/s40620-023-01634-8. Epub 2023 Apr 25.
8
An interpretable machine-learning model for predicting the efficacy of nonsteroidal anti-inflammatory drugs for closing hemodynamically significant patent ductus arteriosus in preterm infants.一种用于预测非甾体抗炎药关闭早产儿血流动力学显著的动脉导管未闭疗效的可解释机器学习模型。
Front Pediatr. 2023 Apr 4;11:1097950. doi: 10.3389/fped.2023.1097950. eCollection 2023.
9
Association between endotypes of prematurity and pharmacological closure of patent ductus arteriosus: A systematic review and meta-analysis.早产内型与动脉导管未闭药物闭合之间的关联:一项系统评价和荟萃分析。
Front Pediatr. 2023 Mar 3;11:1078506. doi: 10.3389/fped.2023.1078506. eCollection 2023.
10
The Need to Address Sex as a Biological Variable in Neonatal Clinical Studies.新生儿临床研究中把性别作为生物学变量加以考量的必要性。
J Pediatr. 2023 Apr;255:17-21. doi: 10.1016/j.jpeds.2022.11.021. Epub 2022 Nov 30.
血小板计数低与早产儿动脉导管未闭有关。
Early Hum Dev. 2012 Oct;88(10):813-6. doi: 10.1016/j.earlhumdev.2012.05.007. Epub 2012 Jun 18.
4
Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.异前列烷作为向新生生命过渡的生理介质:调节足月和早产动脉导管开放的新机制。
Pediatr Res. 2012 Aug;72(2):122-8. doi: 10.1038/pr.2012.58.
5
Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation.动脉导管未闭的解剖性关闭:CD14+/CD163+单核细胞和 VEGF 在新内膜丘形成中的作用。
Pediatr Res. 2011 Oct;70(4):332-8. doi: 10.1203/PDR.0b013e3182294471.
6
Does thrombocytopenia contribute to patent ductus arteriosus?血小板减少症是否会导致动脉导管未闭?
Nat Med. 2011 Jan;17(1):29-30; author reply 30-1. doi: 10.1038/nm0111-29.
7
Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment.吲哚美辛治疗后循环血小板计数与动脉导管未闭的关系。
J Pediatr. 2011 Jun;158(6):919-923.e1-2. doi: 10.1016/j.jpeds.2010.11.018. Epub 2010 Dec 30.
8
Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants.宫内炎症作为极低出生体重儿环氧化酶抑制后持续性动脉导管未闭的危险因素。
J Pediatr. 2010 Nov;157(5):745-50.e1. doi: 10.1016/j.jpeds.2010.05.020. Epub 2010 Jul 2.
9
Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.动脉导管的基因表达模式与持续动脉导管未闭的环境和遗传风险因素有关。
Pediatr Res. 2010 Oct;68(4):292-7. doi: 10.1203/PDR.0b013e3181ed8609.
10
Patent ductus arteriosus of the preterm infant.早产儿动脉导管未闭。
Pediatrics. 2010 May;125(5):1020-30. doi: 10.1542/peds.2009-3506. Epub 2010 Apr 26.